Literature DB >> 8825347

The influence of membrane cholesterol on the GABAA receptor.

P J Bennett1, M A Simmonds.   

Abstract

1. Neurosteroids such as pregnanolone have been established as potent modulators of the GABAA receptor in both electrophysiological and binding studies. Since cholesterol is present in substantial amounts in the neuronal membranes, we have sought evidence for possible interactions of cholesterol with the neurosteroid site and more generally, with the GABAA channel. 2. Synaptosomal membranes were prepared from rat whole brain, cerebral cortex, cerebellum and spinal cord. These membranes were enriched with cholesterol to about double the original level by incubation with liposomes comprised of 50 phosphatidylcholine: 50 cholesterol in the presence of 1% BSA. The additional cholesterol formed a homogeneous mixture with the endogenous cholesterol. 3. The effects of cholesterol and modulatory drugs on the GABAA channel were assessed from the changes induced in [3H]-flunitrazepam (FNZ) binding. Cholesterol enrichment did not affect FNZ binding itself; however, the enhancement of [3H]-FNZ binding by pregnanolone was affected. In membranes from cerebral cortex, the potency of pregnanolone was reduced by a factor of 3.2 following cholesterol enrichment. By contrast, in membranes from spinal cord, the potency of pregnanolone was increased by a factor of 8.4 following cholesterol enrichment. In membranes from cerebellum, there was little overall change in pregnanolone potency although the effects of threshold concentrations were increased. 4. The enhancement of [3H]-FNZ binding by propofol in whole brain membranes was reduced in cholesterol-enriched membranes, similar to the effects of pregnanolone. Experiments with muscimol resulted in an increase in its potency as a potentiator of [3H]-FNZ binding, following cholesterol enrichment. 5. These results provide little evidence for a selective competition between cholesterol and pregnanolone at its binding site. Rather, they suggest an influence of membrane cholesterol on the functional coupling between the benzodiazepine site and the other specific drug sites on the GABAA channel. The detailed pattern of influence depended upon the region of CNS and may be related to the subunit composition of the GABAA channels present.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8825347      PMCID: PMC1909377          DOI: 10.1111/j.1476-5381.1996.tb15158.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

Review 1.  GABAA receptors: ligand-gated Cl- ion channels modulated by multiple drug-binding sites.

Authors:  W Sieghart
Journal:  Trends Pharmacol Sci       Date:  1992-12       Impact factor: 14.819

Review 2.  Molecular and cellular mechanisms of general anaesthesia.

Authors:  N P Franks; W R Lieb
Journal:  Nature       Date:  1994-02-17       Impact factor: 49.962

3.  Sequence and functional expression of the GABA A receptor shows a ligand-gated receptor super-family.

Authors:  P R Schofield; M G Darlison; N Fujita; D R Burt; F A Stephenson; H Rodriguez; L M Rhee; J Ramachandran; V Reale; T A Glencorse
Journal:  Nature       Date:  1987 Jul 16-22       Impact factor: 49.962

4.  Resonance energy transfer assay of protein-mediated lipid transfer between vesicles.

Authors:  J W Nichols; R E Pagano
Journal:  J Biol Chem       Date:  1983-05-10       Impact factor: 5.157

5.  Correlation between acetylcholine receptor function and structural properties of membranes.

Authors:  T M Fong; M G McNamee
Journal:  Biochemistry       Date:  1986-02-25       Impact factor: 3.162

6.  Alteration of synaptic membrane cholesterol/phospholipid ratio using a lipid transfer protein. Effect on gamma-aminobutyric acid uptake.

Authors:  P North; S Fleischer
Journal:  J Biol Chem       Date:  1983-01-25       Impact factor: 5.157

Review 7.  Propofol. A review of its pharmacodynamic and pharmacokinetic properties and use as an intravenous anaesthetic.

Authors:  M S Langley; R C Heel
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

8.  Influence of phospholipid structure on sterol efflux induced by albumin-phospholipid complexes.

Authors:  L C Bartholow; R P Geyer
Journal:  Biochemistry       Date:  1982-03-16       Impact factor: 3.162

9.  Adenylate cyclase is inhibited upon depletion of plasma-membrane cholesterol.

Authors:  A D Whetton; L M Gordon; M D Houslay
Journal:  Biochem J       Date:  1983-05-15       Impact factor: 3.857

10.  Annular and nonannular binding sites for cholesterol associated with the nicotinic acetylcholine receptor.

Authors:  O T Jones; M G McNamee
Journal:  Biochemistry       Date:  1988-04-05       Impact factor: 3.162

View more
  5 in total

Review 1.  24(S)-Hydroxycholesterol as a Modulator of Neuronal Signaling and Survival.

Authors:  Min-Yu Sun; Andrew J Linsenbardt; Christine M Emnett; Lawrence N Eisenman; Yukitoshi Izumi; Charles F Zorumski; Steve Mennerick
Journal:  Neuroscientist       Date:  2015-01-27       Impact factor: 7.519

Review 2.  Functional marriage in plasma membrane: Critical cholesterol level-optimal protein activity.

Authors:  Ulises Meza; Mayra Delgado-Ramírez; Catalina Romero-Méndez; Sergio Sánchez-Armass; Aldo A Rodríguez-Menchaca
Journal:  Br J Pharmacol       Date:  2020-03-24       Impact factor: 8.739

3.  Interaction between cyclodextrin and neuronal membrane results in modulation of GABA(A) receptor conformational transitions.

Authors:  Maria Pytel; Katarzyna Mercik; Jerzy W Mozrzymas
Journal:  Br J Pharmacol       Date:  2006-05-15       Impact factor: 8.739

4.  Membrane tension modulates the effects of apical cholesterol on the renal epithelial sodium channel.

Authors:  Shi-Peng Wei; Xue-Qi Li; Chu-Fang Chou; You-You Liang; Ji-Bin Peng; David G Warnock; He-Ping Ma
Journal:  J Membr Biol       Date:  2007-10-19       Impact factor: 1.843

5.  Brainstem concentrations of cholesterol are not influenced by genetic ablation of the low-density lipoprotein receptor.

Authors:  Ameer Y Taha; Chuck T Chen; Zhen Liu; John H Kim; Howard T J Mount; Richard P Bazinet
Journal:  Neurochem Res       Date:  2008-07-08       Impact factor: 3.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.